全文获取类型
收费全文 | 544篇 |
免费 | 21篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 13篇 |
妇产科学 | 9篇 |
基础医学 | 157篇 |
口腔科学 | 4篇 |
临床医学 | 39篇 |
内科学 | 102篇 |
皮肤病学 | 1篇 |
神经病学 | 18篇 |
特种医学 | 17篇 |
外科学 | 24篇 |
综合类 | 58篇 |
预防医学 | 29篇 |
眼科学 | 5篇 |
药学 | 35篇 |
中国医学 | 20篇 |
肿瘤学 | 32篇 |
出版年
2023年 | 18篇 |
2022年 | 71篇 |
2021年 | 47篇 |
2020年 | 27篇 |
2019年 | 15篇 |
2018年 | 17篇 |
2017年 | 21篇 |
2016年 | 19篇 |
2015年 | 12篇 |
2014年 | 32篇 |
2013年 | 36篇 |
2012年 | 28篇 |
2011年 | 25篇 |
2010年 | 20篇 |
2009年 | 10篇 |
2008年 | 21篇 |
2007年 | 16篇 |
2006年 | 15篇 |
2005年 | 10篇 |
2004年 | 8篇 |
2003年 | 11篇 |
2002年 | 8篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 10篇 |
1998年 | 4篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 1篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有569条查询结果,搜索用时 296 毫秒
31.
Shelain Patel Ravi K. Trehan Gil T. Railton 《Journal of orthopaedics and traumatology》2009,10(4):203-205
An anatomical variant of the pes anserinus encountered during anterior cruciate ligament reconstructive surgery which has
not been previously described is discussed. During routine harvesting, the sartorius fascia was incised and the semitendinosus
and gracilis tendons were identified. At the distal portion, it was noted that each tendon gave off an additional tendinous
slip. The slip from the semitendinosus tendon had attached to the gracilis tendon and vice versa, thereby creating a double
pes anserinus. This variant was used to construct the graft, and at 1 year review the patient had returned to full sporting
activities with no complications encountered. 相似文献
32.
曲美他嗪治疗不稳定型心绞痛67例分析 总被引:4,自引:2,他引:2
目的 研究曲美他嗪治疗不稳定型心绞痛的疗效. 方法 将不稳定型心绞痛患者133例随机分组,对照组66例采取常规治疗,治疗组67例在常规治疗基础上加服曲美他嗪60mg,3次/d,服药14 d后进行疗效评价. 结果 治疗组不稳定型心绞痛疗效分别是:显效46例,有效18例,无效3例,总有效率95.5%.对照组:显效35例,有效20例,无效11例,总有效率83.3%.治疗组与对照组相比(P<0.05);心电图疗效疗效分别是:治疗组显效45例,有效19例,无效3例,总有效率95.5%;对照组显效34例,有效20例,无效12例,总有效率81.8%.两组差异有统计学意义(P<0.05). 结论 曲美他嗪治疗不稳定型心绞痛疗效比较肯定. 相似文献
33.
Joana R. Chora Michael A. Iacocca Lukáš Tichý Hannah Wand C. Lisa Kurtz Heather Zimmermann Annette Leon Maggie Williams Steve E. Humphries Amanda J. Hooper Mark Trinder Liam R. Brunham Alexandre Costa Pereira Cinthia E. Jannes Margaret Chen Jessica Chonis Jian Wang Serra Kim Mafalda Bourbon 《Genetics in medicine》2022,24(2):293-306
PurposeIn 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published consensus standardized guidelines for sequence-level variant classification in Mendelian disorders. To increase accuracy and consistency, the Clinical Genome Resource Familial Hypercholesterolemia (FH) Variant Curation Expert Panel was tasked with optimizing the existing ACMG/AMP framework for disease-specific classification in FH. In this study, we provide consensus recommendations for the most common FH-associated gene, LDLR, where >2300 unique FH-associated variants have been identified.MethodsThe multidisciplinary FH Variant Curation Expert Panel met in person and through frequent emails and conference calls to develop LDLR-specific modifications of ACMG/AMP guidelines. Through iteration, pilot testing, debate, and commentary, consensus among experts was reached.ResultsThe consensus LDLR variant modifications to existing ACMG/AMP guidelines include (1) alteration of population frequency thresholds, (2) delineation of loss-of-function variant types, (3) functional study criteria specifications, (4) cosegregation criteria specifications, and (5) specific use and thresholds for in silico prediction tools, among others.ConclusionEstablishment of these guidelines as the new standard in the clinical laboratory setting will result in a more evidence-based, harmonized method for LDLR variant classification worldwide, thereby improving the care of patients with FH. 相似文献
34.
Amir Hossein Saeidian Leila Youssefian Jianhe Huang Andrew Touati Hassan Vahidnezhad Luke Kowal Matthew Caffet Tamara Wurst Jagmohan Singh Adam E. Snook Ellen Ryu Paolo Fortina Sharon F. Terry Jonathan G. Schoenecker Jouni Uitto Qiaoli Li 《Genetics in medicine》2022,24(1):75-86
PurposeHeritable ectopic mineralization disorders comprise a group of conditions with a broad range of clinical manifestations in nonskeletal connective tissues. We report the genetic findings from a large international cohort of 478 patients afflicted with ectopic mineralization.MethodsSequence variations were identified using a next-generation sequencing panel consisting of 29 genes reported in association with ectopic mineralization. The pathogenicity of select splicing and missense variants was analyzed in experimental systems in vitro and in vivo.ResultsA total of 872 variants of unknown significance as well as likely pathogenic and pathogenic variants were disclosed in 25 genes. A total of 159 distinct variants were identified in 425 patients in ABCC6, the gene responsible for pseudoxanthoma elasticum, a heritable multisystem ectopic mineralization disorder. The interpretation of variant pathogenicity relying on bioinformatic predictions did not provide a consensus. Our in vitro and in vivo functional assessment of 14 ABCC6 variants highlighted this dilemma and provided unambiguous interpretations to their pathogenicity.ConclusionThe results expand the ABCC6 variant repertoire, shed new light on the genetic heterogeneity of heritable ectopic mineralization disorders, and provide evidence that functional characterization in appropriate experimental systems is necessary to determine the pathogenicity of genetic variants. 相似文献
35.
Joseph M. Collaco Karen S. Raraigh Joshua Betz Melis Atalar Aksit Nenad Blau Jordan Brown Harry C. Dietz Gretchen MacCarrick Lawrence M. Nogee Molly B. Sheridan Hilary J. Vernon Terri H. Beaty Thomas A. Louis Garry R. Cutting 《Genetics in medicine》2022,24(1):87-99
PurposeThe growing size of public variant repositories prompted us to test the accuracy of pathogenicity prediction of DNA variants using population data alone.MethodsUnder the a priori assumption that the ratio of the prevalence of variants in healthy population vs that in affected populations form 2 distinct distributions (pathogenic and benign), we used a Bayesian method to assign probability to a variant belonging to either distribution.ResultsThe approach, termed Bayesian prevalence ratio (BayPR), accurately parsed 300 of 313 expertly curated CFTR variants: 284 of 296 pathogenic/likely pathogenic variants in 1 distribution and 16 of 17 benign/likely benign variants in another. BayPR produced an area under the receiver operating characteristic curve of 0.99 for 103 functionally confirmed missense CFTR variants, which is equal to or exceeds 10 commonly used algorithms (area under the receiver operating characteristic curve range = 0.54-0.99). Application of BayPR to expertly curated variants in 8 genes associated with 7 Mendelian conditions led to the assignment of a disease-causing probability of ≥80% to 1350 of 1374 (98.3%) pathogenic/likely pathogenic variants and of ≤20% to 22 of 23 (95.7%) benign/likely benign variants.ConclusionIrrespective of the variant type or functional effect, the BayPR approach provides probabilities of pathogenicity for DNA variants responsible for Mendelian disorders using only the variant counts in affected and unaffected population samples. 相似文献
36.
《Genetics in medicine》2022,24(9):1821-1830
PurposeHeritable pathogenic variants in the DNA mismatch repair (MMR) pathway cause Lynch syndrome, a condition that significantly increases risk of colorectal and other cancers. At least half of individuals tested using gene panel sequencing have a variant of uncertain significance or no variant identified leading to no diagnosis. To fill this diagnostic gap, we developed Cancer Risk C (CR-C), a flow variant assay test.MethodsIn response to treatment with an alkylating agent, individual assays of the nuclear translocation of MLH1, MSH2, BARD1, PMS2, and BRCA2 proteins and the nuclear phosphorylation of the ATM and ATR proteins distinguished pathogenic/likely pathogenic (P/LP) from benign/likely benign variants in MMR genes.ResultsA risk classification score based on MLH1, MSH2, and ATR assays was 100% sensitive and 98% specific. Causality of MMR P/LP variants was shown through gene editing and rescue. In individuals with suspected Lynch syndrome but no P/LP, CR-C identified most (73%) as having germline MMR defects. Direct comparison of CR-C on matched blood samples and lymphoblastoid cell lines yielded comparable results (r2 > 0.9).ConclusionFor identifying germline MMR defects, CR-C provides augmentation to traditional panel sequencing through greater accuracy, shorter turnaround time (48 hours), and performance on blood with minimal sample handling. 相似文献
37.
《Genetics in medicine》2022,24(9):1857-1866
PurposePenetrance estimates of Birt-Hogg-Dubé syndrome (BHD)-associated cutaneous, pulmonary, and kidney manifestations are based on clinically ascertained families. In a health care system population, we used a genetics-first approach to estimate the prevalence of pathogenic/likely pathogenic (P/LP) truncating variants in FLCN, which cause BHD, and the penetrance of BHD-related phenotypes.MethodsExomes from 135,990 patient-participants in Geisinger’s MyCode cohort were assessed for P/LP truncating FLCN variants. BHD-related phenotypes were evaluated from electronic health records. Association between P/LP FLCN variants and BHD-related phenotypes was assessed using Firth’s logistic regression.ResultsP/LP truncating FLCN variants were identified in 35 individuals (1 in 3234 unrelated individuals), 68.6% of whom had BHD-related phenotype(s), including cystic lung disease (65.7%), pneumothoraces (17.1%), cutaneous manifestations (8.6%), and kidney cancer (2.9%). A total of 4 (11.4%) individuals had prior clinical BHD diagnoses.ConclusionIn this health care population, the frequency of P/LP truncating FLCN variants is 60 times higher than the previously reported prevalence. Although most variant-positive individuals had BHD-related phenotypes, a minority were previously clinically diagnosed, likely because cutaneous manifestations, pneumothoraces, and kidney cancer were observed at lower frequencies than in clinical cohorts. Improved clinical recognition of cystic lung disease and education concerning its association with FLCN variants could prompt evaluation for BHD. 相似文献
38.
Jennifer J. Johnston Marie-Luise Brennan Bailey Radenbaugh Seeley J. Yoo Sophia M. Hernandez Katie L. Lewis Alexander E. Katz Teri A. Manolio Leslie G. Biesecker 《Genetics in medicine》2022,24(3):736-743
PurposeThe American College of Medical Genetics and Genomics (ACMG) recommends the return of pathogenic and likely pathogenic (P/LP) secondary findings from exome and genome sequencing. The latest version (ACMG secondary finding [SF] v3.0) includes 14 additional genes. We interrogated the ClinSeq cohort for variants in these genes to determine the additional yield in unselected individuals.MethodsExome data from 1473 individuals (60% White, 34% African American or Black, 6% other) were analyzed. We restricted our analyses to coding variants; +1,+2,–1, and –2 splice site variants; and the pathogenic GAA variant, NM_000152.5:c.-32-13T>G. Variants were assessed with slightly modified ACMG/Association of Molecular Pathology guidelines.ResultsA total of 25 P/LP variants were identified. In total, 7 individuals had P/LP variants in genes recommended for return of heterozygous variants, namely HNF1A (1), PALB2 (3), TMEM127 (1), and TTN (2). In total, 4 individuals had a homozygous variant in a gene recommended for biallelic variant return, namely HFE, NM_000410.3(HFE):c.845G>A p.Cys282Tyr. A total of 17 P/LP variants were identified in the heterozygous state in genes recommended only for biallelic variant reporting and were not returned. The frequency of returnable P/LP variants did not significantly differ by race.ConclusionUsing the ACMG SF v3.0, the returnable P/LP variant frequency increased in the ClinSeq cohort by 22%, from 3.4% (n = 50, ACMG SF v2.0) to 4.1% (n = 61, ACMG SF v3.0). 相似文献
39.
《European journal of medical genetics》2022,65(1):104398
MED13L syndrome is a rare congenital disorder comprising moderate intellectual disability, hypotonia and facial dysmorphism. Whole exome or genome sequencing in patients with non-specific neurodevelopmental disorders leads to identification of an increasing number of MED13L missense variations of unknown signification. The aim of our study was to identify relevant annotation parameters enhancing discrimination between candidate pathogenic or neutral missense variations, and to assess the performance of seven meta-predictor algorithms: BayesDel, CADD, DANN, FATHMM-XF, M-CAP, MISTIC and REVEL for the classification of MED13L missense variants. Significant differences were identified for five parameters: global conservation through verPhyloP and verPhCons scores; physico-chemical difference between amino acids estimated by Grantham scores; conservation of residues between MED13L and MED13 protein; proximity to phosphorylation sites for pathogenic variations. Among the seven selected in-silico tools, BayesDel, REVEL, and MISTIC provided the most interesting performances to discriminate pathogenic from neutral missense variations.Individual gene parameter studies with MED13L have provided expertise on elements of annotation improving meta-predictor choices. The in-silico approach allows us to make valuable hypotheses to predict the involvement of these amino acids in MED13L pathogenic missense variations. 相似文献
40.
Tatjana Bierhals Georg Christoph Korenke Martina Baethmann Laura López Marín Martin Staudt Kerstin Kutsche 《European journal of medical genetics》2018,61(6):329-334
Congenital mirror movements (CMM) are involuntary movements of one side of the body that mirror intentional movements of the other side. Heterozygous missense, frameshift and nonsense variants and small intragenic deletions in DCC cause CMM, isolated agenesis of the corpus callosum (ACC) or both. We report here the clinical phenotype and natural history of ten individuals with CMM carrying five different monoallelic DCC variants, including the missense variant p.(Trp273Arg), two duplications, one deletion and one deletion-insertion; all are novel and absent from databases. We re-evaluated the 15 known disease-associated DCC missense variants by determining minor allele frequency (MAF) and pathogenicity using four in silico tools combining previous pathogenicity scores and the ACMG/AMP standards and guidelines and classified them in three groups. Group I contains three DCC missense variants that are rather unlikely to be associated with a higher risk to CMM and/or ACC. The five variants in group II may represent susceptibility factors to altered midline crossing in the central nervous system. Group III includes seven variants absent in publically available databases and representing possible pathogenic alleles, with four predicted to have a severe impact on protein function. Based on this data and the variable expressivity and incomplete penetrance present in heterozygous carriers of a DCC variant, classification and clinical interpretation of missense variants is challenging in the absence of evidence of pathogenicity originated from functional studies. Evaluation of missense variants by MAF and a weighted combination of several computational algorithms is recommended. 相似文献